ストックスクリーナーアプリを入手
0.816
32.70%
0.1989
前日終値:
$0.6171
開ける：
$0.8048
24時間の取引高:
142.39M
Relative Volume:
6.21
時価総額：
$81.00M
収益：
-
当期純損益:
$-12.89M
株価収益率:
-0.3225
EPS:
-2.53
ネットキャッシュフロー:
$-11.95M
1週間 パフォーマンス:
+93.46%
1か月 パフォーマンス:
+79.58%
6か月 パフォーマンス:
-29.41%
1年 パフォーマンス:
-55.74%
1日の値動き範囲:
$0.7079
$0.8685
1週間の範囲:
$0.3875
$0.8685
52週間の値動き範囲:
$0.1634
$2.3099
Plus Therapeutics Inc Stock (PSTV) Company Profile
PSTV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PSTV
Plus Therapeutics Inc
|
0.816 | 61.26M | 0 | -12.89M | -11.95M | -2.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.81 | 98.90B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.60 | 58.51B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.79 | 59.77B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
715.96 | 43.55B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.52 | 35.81B | 3.81B | -644.79M | -669.77M | -6.24 |
Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-03 | アップグレード | D. Boral Capital | Hold → Buy |
| 2025-03-17 | 開始されました | D. Boral Capital | Buy |
| 2021-01-25 | 開始されました | Ladenburg Thalmann | Buy |
| 2020-10-16 | 開始されました | Maxim Group | Buy |
Plus Therapeutics Inc (PSTV) 最新ニュース
Plus Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:PSTV - Benzinga
H.C. Wainwright Maintains Plus Therapeutics(PSTV.US) With Buy Rating, Maintains Target Price $3 - 富途牛牛
Why Cidara Therapeutics Was Such a Healthy Stock Today - AOL.com
Maxim Group Maintains Plus Therapeutics(PSTV.US) With Buy Rating, Maintains Target Price $3 - 富途牛牛
Buy Rating for Plus Therapeutics Driven by Strategic Advancements and Market Expansion for CNSide Test - TipRanks
Plus Therapeutics (PSTV) Stock Rallies as UnitedHealthcare Approves Cancer Test Coverage - parameter.io
Why CytomX Therapeutics Stock Was Skyrocketing This Week - AOL.com
Plus Therapeutics (PSTV) Soars 40% as Firm Seals Partnership with United Healthcare - MSN
PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients - ts2.tech
Massive Gains: 10 Stocks Investors Can’t Stop Buying - Insider Monkey
These 3 Penny Stocks are Soaring Today: PLUS, EVAX, DVLT - AOL.com
Plus Therapeutics Shares Surge After UnitedHealthcare Coverage Deal - MSN
Buy Rating for Plus Therapeutics Driven by CNSide Coverage and Promising Pipeline Developments - TipRanks
Plus Therapeutics (PSTV) Rockets 40% on Major Insurance Win for Cancer Detection Tool – Here's Why Traders Are Buzzing - RagingBull
Plus Therapeutics Pops on UNH Pact - Baystreet.ca
Plus Therapeutics (PSTX) Surges After Securing UnitedHealthcare Coverage for CNSide Test - GuruFocus
Plus Therapeutics stock soars after UnitedHealthcare agreement By Investing.com - Investing.com Nigeria
Plus Therapeutics stock soars after UnitedHealthcare agreement - Investing.com
PSTV: D. Boral Capital Maintains 'Buy' Rating with $5 PT | PSTV Stock News - GuruFocus
Plus Therapeutics rises on the back of UnitedHealthcare coverage deal - Seeking Alpha
D. Boral Capital Maintains Plus Therapeutics (PSTV) Buy Recommendation - Nasdaq
Plus Therapeutics announces national coverage agreement with UnitedHealthcare - TipRanks
Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer - The Manila Times
Plus Therapeutics Announces National Coverage Agreement - GlobeNewswire
Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare For CNS Cancer Diagnostic Kit - Yahoo Finance
51 Million Americans Gain Access: Plus Therapeutics' 92% Accurate Cancer Test Wins Major Insurance Deal - Stock Titan
Plus Therapeutics receives $1.9 million payment from cancer research fund By Investing.com - Investing.com Nigeria
Plus Therapeutics Announces Additional $1.9 Million Advance Payment from CPRIT - GlobeNewswire
Plus Therapeutics receives $1.9 million payment from cancer research fund - Investing.com India
Plus Therapeutics receives $1.9M CPRIT payment for cancer program - MSN
Plus Therapeutics (PSTV) Analyst Rating Maintained at 'Buy' by D. Boral Capital | PSTV Stock News - GuruFocus
Plus Therapeutics (PSTV) Secures Additional $1.9M Funding from C - GuruFocus
Plus Therapeutics announces $1.9M advance payment from CPRIT - TipRanks
Plus Therapeutics, Inc. Secures $1.9 Million Payment from CPRIT as Part of $17.6 Million Grant for Leptomeningeal Cancer Treatment Development - Quiver Quantitative
$17.6M Cancer Research Grant: Plus Therapeutics Receives Second Payment for CNS Cancer Treatment Trial - Stock Titan
Fund Flows: Is Plus Therapeutics Inc. stock showing strong momentumEarnings Miss & Community Consensus Stock Picks - خودرو بانک
Market Pulse: Is Plus Therapeutics Inc forming bullish engulfing patterns2025 EndofYear Setup & Fast Gain Stock Trading Tips - خودرو بانک
Winners Losers: Should you avoid Plus Therapeutics Inc stock right nowWeekly Trade Analysis & Real-Time Buy Zone Alerts - khodrobank.com
Analyst Downgrade: What dividend growth rate does Plus Therapeutics Inc offerJuly 2025 Macro Moves & Entry Point Confirmation Alerts - خودرو بانک
Technical Analysis: What dividend growth rate does Plus Therapeutics Inc offer2025 Support & Resistance & Stepwise Swing Trade Plans - خودرو بانک
Should you avoid Plus Therapeutics Inc. stock right nowJuly 2025 Big Picture & High Conviction Investment Ideas - khodrobank.com
Plus Therapeutics Announces Successful Accreditation and Certification for Its CNSide Diagnostics Clinical Laboratory - citybiz
Plus Therapeutics Announces Successful Accreditation and - GlobeNewswire
Breakout Watch: Can Plus Therapeutics Inc reach all time highs this yearMarket Risk Report & Community Verified Trade Alerts - خودرو بانک
Plus Therapeutics (PSTV) Rating Maintained as 'Buy' by D. Boral Capital | PSTV Stock News - GuruFocus
CNSide Diagnostics Achieves Key Accreditation Milestone for Hous - GuruFocus
Aug Wrap: What is the dividend yield of Plus Therapeutics IncMarket Trend Summary & Community Trade Idea Sharing Platform - khodrobank.com
Major Regulatory Milestone: Plus Therapeutics' CNSide Lab Gets Federal Approval for CNS Cancer Testing - Stock Titan
Aug Momentum: Will Plus Therapeutics Inc. benefit from sector rotation2025 Market Trends & Technical Pattern Based Signals - خودرو بانک
Returns Recap: What is Plus Therapeutics Inc.’s valuation compared to sectorQuarterly Performance Summary & Consistent Profit Trade Alerts - khodrobank.com
Levels Update: What is the long term forecast for Plus Therapeutics Inc. stockIPO Watch & Comprehensive Market Scan Insights - khodrobank.com
Plus Therapeutics Inc (PSTV) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.33%
大文字化:
|
ボリューム (24 時間):